Here is the breakdown for 2016 market share and predictions for 2022, according to Statista.
1. Johnson & Johnson had 25.1 percent market share in 2016 and is expected to have 22.8 percent in 2022.
2. Zimmer Biomet had 20.7 percent market share in 2016 and is expected to have 19.8 percent in 2022.
3. Stryker had 16.1 percent market share in 2016 and is expected to have 17.1 percent in 2022.
4. Medtronic had 7.9 percent market share in 2016 and is expected to have 8.4 percent in 2022.
5. Smith & Nephew had 5.7 percent market share in 2016 and is expected to have 5.5 percent in 2022.
6. Arthrex had 4.9 percent market share in 2016 and is expected to have the same, 4.9 percent, in 2022.
7. NuVasive had 2.5 percent market share in 2016 and is expected to have 2.9 percent in 2022.
8. Wright Medical Group had 2 percent market share in 2016 and is expected to have 2.9 percent in 2022.
9. Globus Medical had 1.6 percent market share in 2016 and is expected to have 2 percent in 2022.
10. Orthofix had 1.2 percent market share in 2016 and is expected to have 1.1 percent in 2022.
More articles on orthopedic devices:
K2M names new COO: 5 things to know about Lane Major
Medtronic, J&J, Smith & Nephew & more: 10 device company notes
Medtronic to redeem $1.2B company shares: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
